Co-Diagnostics, Inc. Gain (Loss) on Sale of Investments
Co-Diagnostics, Inc. (CODX) reported Gain (Loss) on Sale of Investments of -$52.16 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:GainLossOnSaleOfInvestments · last filed 2026-08-13
- Co-Diagnostics, Inc. gain (loss) on sale of investments for the quarter ending 2026-06-30 was -$52.16K.
- Co-Diagnostics, Inc. gain (loss) on sale of investments for the quarter ending 2026-03-31 was -$13.36K.
- Co-Diagnostics, Inc. gain (loss) on sale of investments for the quarter ending 2025-12-31 was $24.86K.
- Co-Diagnostics, Inc. gain (loss) on sale of investments for the quarter ending 2025-09-30 was -$55.96K, a 541.21% decline year-over-year.
- Co-Diagnostics, Inc. gain (loss) on sale of investments for fiscal 2025 was -$46.30K.
- Co-Diagnostics, Inc. gain (loss) on sale of investments for fiscal 2024 was -$186.07K, a 284.77% decline from fiscal 2023.
- Co-Diagnostics, Inc. gain (loss) on sale of investments for fiscal 2023 was $100.70K.
- Co-Diagnostics, Inc. gain (loss) on sale of investments for fiscal 2022 was -$332.97K.
| Period end | Gain (Loss) on Sale of Investments 3 month | Gain (Loss) on Sale of Investments 6 month | Gain (Loss) on Sale of Investments 9 month | Gain (Loss) on Sale of Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$52.16K 10-Q · filed 2026-08-13 | -$65.52K 10-Q · filed 2026-08-13 | -$40.66K derived: sum of 3 quarters · filed 2026-08-13 | -$96.61K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$13.36K 10-Q · filed 2026-05-14 | $11.50K derived: sum of 2 quarters · filed 2026-05-14 | -$44.46K derived: sum of 3 quarters · filed 2026-05-14 | -$58.22K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $24.86K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$31.10K derived: sum of 2 quarters · filed 2026-03-31 | -$44.86K derived: sum of 3 quarters · filed 2026-08-13 | -$46.30K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$55.96K 10-Q · filed 2025-11-13 | -$69.72K derived: sum of 2 quarters · filed 2026-08-13 | -$71.16K 10-Q · filed 2025-11-13 | -$124.45K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$13.76K 10-Q · filed 2026-08-13 | -$15.20K 10-Q · filed 2026-08-13 | -$68.50K derived: sum of 3 quarters · filed 2026-08-13 | -$55.81K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$1.44K 10-Q · filed 2026-05-14 | -$54.74K derived: sum of 2 quarters · filed 2026-05-14 | -$42.05K derived: sum of 3 quarters · filed 2026-05-14 | -$116.56K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$53.29K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$40.61K derived: sum of 2 quarters · filed 2026-03-31 | -$115.11K derived: sum of 3 quarters · filed 2026-03-31 | -$186.07K 10-K · filed 2026-03-31 |
| 2024-09-30 | $12.68K 10-Q · filed 2025-11-13 | -$61.82K derived: sum of 2 quarters · filed 2025-11-13 | -$132.78K 10-Q · filed 2025-11-13 | -$138.34K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$74.50K 10-Q · filed 2025-08-14 | -$145.46K 10-Q · filed 2025-08-14 | -$151.02K derived: sum of 3 quarters · filed 2025-08-14 | -$196.88K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$70.95K 10-Q · filed 2025-05-08 | -$76.52K derived: sum of 2 quarters · filed 2025-05-08 | -$122.38K derived: sum of 3 quarters · filed 2025-05-08 | -$247.57K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$5.56K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$51.43K derived: sum of 2 quarters · filed 2025-03-27 | -$176.62K derived: sum of 3 quarters · filed 2025-03-27 | $100.70K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$45.87K 10-Q · filed 2024-11-07 | -$171.06K derived: sum of 2 quarters · filed 2024-11-07 | $106.26K 10-Q · filed 2024-11-07 | $30.21K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$125.19K 10-Q · filed 2024-08-08 | $152.13K 10-Q · filed 2024-08-08 | $76.07K derived: sum of 3 quarters · filed 2024-08-08 | -$52.98K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $277.32K 10-Q · filed 2024-05-09 | $201.26K derived: sum of 2 quarters · filed 2024-05-09 | $72.22K derived: sum of 3 quarters · filed 2024-05-09 | -$34.31K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$76.06K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$205.10K derived: sum of 2 quarters · filed 2024-03-14 | -$311.63K derived: sum of 3 quarters · filed 2024-03-14 | -$332.97K 10-K · filed 2024-03-14 |
| 2022-09-30 | -$129.05K 10-Q · filed 2023-11-09 | -$235.57K derived: sum of 2 quarters · filed 2023-11-09 | -$256.91K 10-Q · filed 2023-11-09 | -$286.06K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$106.53K 10-Q · filed 2023-08-10 | -$127.86K 10-Q · filed 2023-08-10 | -$157.01K derived: sum of 3 quarters · filed 2023-08-10 | -$221.95K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$21.34K 10-Q · filed 2023-05-11 | -$50.48K derived: sum of 2 quarters · filed 2023-05-11 | -$115.42K derived: sum of 3 quarters · filed 2023-05-11 | $13.17K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$29.14K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$94.08K derived: sum of 2 quarters · filed 2023-03-16 | $34.51K derived: sum of 3 quarters · filed 2023-03-16 | -$430.43K 10-K · filed 2023-03-16 |
| 2021-09-30 | -$64.94K 10-Q · filed 2022-11-10 | $63.66K derived: sum of 2 quarters · filed 2022-11-10 | -$401.29K 10-Q · filed 2022-11-10 | -$639.20K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $128.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$336.35K 10-Q · filed 2022-08-11 | -$574.26K derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$464.94K 10-Q · filed 2022-05-12 | -$702.86K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$237.91K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $778.38K 10-K · filed 2022-03-24 | ||
| 2020-09-30 | $1.02M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |